AMAG Pharmaceuticals, Inc. and March of Dimes Announce Collaboration to Improve Health of Mothers and Babies
Waltham, Mass. and White Plains, NY | Monday, June 11, 2018
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and March of Dimes today announced a strategic corporate partnership focused on a shared commitment to improve maternal health and birth outcomes, as well as to reduce health inequities. Through the partnership, AMAG will participate in the March of Dimes Prematurity Campaign Collaborative and support the expansion of the March of Dimes' Supportive Pregnancy Care (SPC) model, an innovative group prenatal care program.
"AMAG's commitment to support the health of patients and families encompasses far more than the therapies we offer to help moms and babies. We also focus on how we can help address broader unmet needs these families may be experiencing that impact their health and well-being," said William Heiden, president and chief executive officer, AMAG Pharmaceuticals. "We are grateful for the opportunity to collaborate with March of Dimes to build on our existing efforts, and to advance both national and community-level initiatives aimed at giving expectant mothers and families the tools, resources and support they need to achieve healthy pregnancies and births."
The March of Dimes Prematurity Campaign Collaborative aims to achieve health equity and demonstrated improvements in preterm birth outcomes. AMAG will contribute to the Collaborative in areas related to maternal and infant health equity, drawing on the company’s expertise in maternal health and standing collaborations with experts and clinicians to address this issue.
Additionally, AMAG's support of the SPC program will create nine additional group prenatal care programs in site locations throughout the country. SPC seeks to improve health outcomes for mothers and babies by supplementing traditional medical care with social support, health education and skill-building in a group setting with a team of clinicians.
"The health of mothers and babies is critical to the overall health of our communities, and the work of our Prematurity Campaign Collaborative and Supportive Pregnancy Care program are focused on helping families and communities thrive," said Stacey D. Stewart, President, March of Dimes. "With AMAG Pharmaceuticals, we are able to make even greater progress on improving health equity and access to comprehensive prenatal care, which can have a substantial impact on pregnancy and birth outcomes, as well as overall community health."
About March of Dimes
March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family.